查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386501

脑肿瘤诊断市场报告：2030 年趋势、预测与竞争分析

Brain Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

脑肿瘤诊断的趋势和预测

预计到 2030 年，全球脑瘤诊断市场将达到 93 亿美元，2024 年至 2030 年复合年增长率为 23.7%。这个市场的主要驱动因素是脑肿瘤患者数量的增加、对脑肿瘤早期诊断的认识不断提高以及与脑肿瘤细胞相关的药物输送系统的创新。全球脑瘤诊断市场前景广阔，医院、专科诊所、诊断中心/研究机构、门诊手术中心市场都有商机。

脑肿瘤诊断市场洞察

Lucintel 预测，由于生活方式、遗传因素和诊断系统改进等病因趋势，多形性胶质母细胞瘤将继续成为最大的部分。

在同一市场中，由于脑肿瘤的增加、医院基础设施的改善以及癌症诊断投资和资金筹措的增加，医院在预测期内预计将出现最高的增长。

由于研发活动的活性化和成像技术的改进，北美仍然是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球脑肿瘤诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球脑肿瘤诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按测试类型分類的全球脑肿瘤诊断市场
    • 影像检查
    • 切片检查
    • 腰椎穿刺
    • 分子检测
    • 脑电图测试
    • 其他的
  • 按癌症类型分類的全球脑肿瘤诊断市场
    • 听神经瘤
    • 星状细胞瘤
    • 多形性胶质母细胞瘤
    • 脑膜瘤
    • 少突胶质细胞瘤
    • 其他的
  • 按年龄组别分類的全球脑肿瘤诊断市场
    • 孩子
    • 成人
    • 老人
  • 按最终用途分類的全球脑肿瘤诊断市场
    • 医院
    • 专科诊所
    • 诊断中心和研究所
    • 门诊手术中心
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球脑肿瘤诊断市场（按地区）
  • 北美脑肿瘤诊断市场
  • 欧洲脑肿瘤诊断市场
  • 亚太地区脑肿瘤诊断市场
  • 其他区域脑肿瘤诊断市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按测试类型分類的全球脑肿瘤诊断市场成长机会
    • 按癌症类型分類的全球脑肿瘤诊断市场成长机会
    • 按年龄组别分類的全球脑肿瘤诊断市场成长机会
    • 全球脑肿瘤诊断市场最终用途的成长机会
    • 按地区分類的全球脑肿瘤诊断市场成长机会
  • 全球脑肿瘤诊断市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球脑肿瘤诊断市场的产能扩张
    • 全球脑肿瘤诊断市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • NantOmics
  • GE Healthcare
  • NIHON KOHDEN
  • Canon
  • FUJIFILM Holdings
简介目录

Brain Cancer Diagnostic Trends and Forecast

The future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

A more than 150-page report is developed to help in your business decisions.

Brain Cancer Diagnostic by Segment

The study includes a forecast for the global brain cancer diagnostic by test type, cancer type, age group, end use, and region.

Brain Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging Test
  • Biopsy
  • Lumber Puncture
  • Molecular Testing
  • Electroencephalography
  • Others

Brain Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acoustic Neuroma
  • Astrocytomas
  • Glioblastoma Multiforme
  • Meningiomas
  • Oligodendroglioma
  • Others

Brain Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult
  • Geriatic

Brain Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers & Research Institutes
  • Ambulatory Surgical Centers
  • Others

Brain Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Brain Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain cancer diagnostic companies profiled in this report include-

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Brain Cancer Diagnostic Market Insights

Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Within this market, hospitals is expected to witness highest growth over the forecast period due to increasing prevelance of brain cancer, improvement in the hospital infrastructure, and rising investments and funding in cancer daignostics.

North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Features of the Global Brain Cancer Diagnostic Market

Market Size Estimates: Brain cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain cancer diagnostic market size by various segments, such as by test type, cancer type, age group, end use, and region in terms of ($B).

Regional Analysis: Brain cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, cancer types, age groups, end uses, and regions for the brain cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the brain cancer diagnostic market size?

Answer: The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030.

Q.2 What is the growth forecast for brain cancer diagnostic market?

Answer: The global brain cancer diagnostic market is expected to grow with a CAGR of 23.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the brain cancer diagnostic market?

Answer: The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

Q4. What are the major segments for brain cancer diagnostic market?

Answer: The future of the brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets.

Q5. Who are the key brain cancer diagnostic market companies?

Answer: Some of the key brain cancer diagnostic companies are as follows:

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Q6. Which brain cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Q7. In brain cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the brain cancer diagnostic market by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Brain Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Brain Cancer Diagnostic Market by Test Type
    • 3.3.1: Imaging Test
    • 3.3.2: Biopsy
    • 3.3.3: Lumber Puncture
    • 3.3.4: Molecular Testing
    • 3.3.5: Electroencephalography
    • 3.3.6: Others
  • 3.4: Global Brain Cancer Diagnostic Market by Cancer Type
    • 3.4.1: Acoustic Neuroma
    • 3.4.2: Astrocytomas
    • 3.4.3: Glioblastoma Multiforme
    • 3.4.4: Meningiomas
    • 3.4.5: Oligodendroglioma
    • 3.4.6: Others
  • 3.5: Global Brain Cancer Diagnostic Market by Age Group
    • 3.5.1: Children
    • 3.5.2: Adult
    • 3.5.3: Geriatic
  • 3.6: Global Brain Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Specialty Clinics
    • 3.6.3: Diagnostic Centers & Research Institutes
    • 3.6.4: Ambulatory Surgical Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Brain Cancer Diagnostic Market by Region
  • 4.2: North American Brain Cancer Diagnostic Market
    • 4.2.2: North American Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.3: European Brain Cancer Diagnostic Market
    • 4.3.1: European Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.3.2: European Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Brain Cancer Diagnostic Market
    • 4.4.1: APAC Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.4.2: APAC Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Brain Cancer Diagnostic Market
    • 4.5.1: ROW Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.5.2: ROW Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Brain Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Brain Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Brain Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Siemens Healthcare Diagnostics
  • 7.3: Hologic
  • 7.4: NantOmics
  • 7.5: GE Healthcare
  • 7.6: NIHON KOHDEN
  • 7.7: Canon
  • 7.8: FUJIFILM Holdings